A Study to Evaluate Enfortumab Vedotin in Subjects With Locally Advanced or Metastatic Malignant Solid Tumors (EV-202)

NCT04225117 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

329

Enrollment

INDUSTRY

Sponsor class

Conditions

Locally Advanced or Metastatic Malignant Solid Tumors

Interventions

DRUG: enfortumab vedotin
DRUG: pembrolizumab

Sponsor

Astellas Pharma Global Development, Inc.

Collaborators

[object Object]
[object Object]